BIIB Summary

  1. NASDAQ
  2. >
  3. BIIB
TickerBIIB
DescriptionBIOGEN INC
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees7,400
Next Earnings DateFebruary 4th, 2021
IV98.313249%
IV Percentile99th
IV Rank96.57%
IV Skew-3.274131
IV Skew Percentile6th
IV Skew SentimentBullish
Option Volume21,895
Volume1,240,965
Price$256.76
Previous Close$265.00
52-Week High$374.99
52-Week Low$257.60
50-Day Moving Avg.$278.50
200-Day Moving Avg.$293.04
10-Day Avg. Volume1,099,638
20-Day Avg. Volume1,026,741
30-Day Avg. Volume1,120,055
3-Month Avg. Volume1,172,632
PE8.79947
EPS$30.32
Outstanding Shares153,882,000
Float153,617,323
Market Capitalization$41,055,610,100
CurrencyUSD
UpdatedOctober 26th, 2020